Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenapanor for correction of excess fluid volume in peritoneal dialysis patients
jRCT1031250075Recruiting
- Sponsor
- Dokkyo Medical University Saitama Medical Center
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tenapanor in chronic kidney disease (CKD), sponsored by Dokkyo Medical University Saitama Medical Center. Primary endpoint: Extracellular fluid volume by impedance. Started Mar 2025; status: recruiting.
02
Drugs
tenapanor
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT1031250075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031250075.